Why is Transgene Biotek falling/rising?

As of 23-Sep, Transgene Biotek Ltd's stock price is currently at 4.00, reflecting an increase of 0.05, or 1.27%. The stock has shown a positive trend recently, gaining for the last two days with a total return of 4.17% during this period. However, it has underperformed over the longer term, with a year-to-date decline of 41.43% and a one-year drop of 50.06%. Additionally, the stock's delivery volume has significantly decreased by 95.73% compared to the five-day average, indicating falling investor participation. There are no specific positive or negative factors available to further explain the stock's recent movement.
Broader market context shows that while Transgene Biotek has outperformed its sector by 1.74% today, it has still struggled in comparison to the benchmark Sensex, which has gained 5.07% year-to-date. Over the past week, the stock has declined by 5.44%, contrasting with the Sensex's minor drop of 0.34%. This suggests that despite the recent uptick, the stock remains under pressure in the broader market environment, which has generally been more favorable.